Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women
- whether the intake of n-3 PUFA has additional effects on insulin sensitivity and adiposity (total fat mass and adipocyte morphology and function) in T2D women.
- n-3 PUFA supplementation might influence inflammatory genes expression in the adipose tissue of T2D patients.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- The effect of 2 month treatment on:
- adiposity (total fat mass, adipocyte morphology), atherogenic markers and insulin sensitivity
- the underlying mechanisms of the observed results and tried to define new targets of fish oil metabolic effects
- and the impact of fish oil on systemic inflammatory markers and adipose tissue inflammatory genes.
|Study Start Date:||December 2002|
|Estimated Study Completion Date:||April 2005|
Thus, the present study was designed to evaluate the effects of n-3 PUFAs dietary supplementation on lipid and glucose homeostasis and to address the impact of this treatment on adiposity and adipose tissue gene expression in T2D women.A total of 27 T2D women (BMI 27-35kg/m², age 40-60 y) were randomly allocated to two months of 3 g/day of either fish oil (1.8 g n-3 PUFA) or placebo (paraffin oil), in a double-blind parallel design.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00371982
|Department of Diabetes-Hotel Dieu Hospital|
|Paris, France, 75004|
|Study Director:||Salwa W Rizkalla, MD,PhD||INSERM (National institution of Health and Medical Research)|
|Study Chair:||Gerard Slama, MD, professor||Public Assistance-Paris Hospitals (AP-HP), University Paris 6|